CHMP Opinions July 2026
The CHMP (Committee for Medicinal Products for Human Use) is the EMA committee whose monthly opinions decide whether new medicines are recommended for approval in the EU. A positive opinion is normally followed by European Commission authorisation within ~67 days. Dates below come from official CHMP meeting agendas and highlights.
- CHMP opinion ALM.MC Almirall S.A. CHMP agenda item: Almirall S.A. — Ilumetri 2026-07-23
- CHMP opinion AMGN Amgen Inc. CHMP agenda item: Amgen Inc. — Kyprolis 2026-07-23
- CHMP opinion AMGN Amgen Inc. CHMP positive opinion: Amgen Inc. — Repatha 2026-07-23
- CHMP opinion AZN AstraZeneca PLC CHMP agenda item: AstraZeneca PLC — Fluenz 2026-07-23
- CHMP opinion AZN AstraZeneca PLC CHMP positive opinion: AstraZeneca PLC — Riltrava Aerosphere 2026-07-23
- CHMP opinion AZN AstraZeneca PLC CHMP agenda item: AstraZeneca PLC — Saphnelo 2026-07-23
- CHMP opinion AZN AstraZeneca PLC CHMP agenda item: AstraZeneca PLC — TAGRISSO 2026-07-23
- CHMP opinion AZN AstraZeneca PLC CHMP positive opinion: AstraZeneca PLC — Trixeo Aerosphere 2026-07-23
- CHMP opinion BAYN.DE Bayer AG CHMP agenda item: Bayer AG — Betaferon 2026-07-23
- CHMP opinion BAYN.DE Bayer AG CHMP positive opinion: Bayer AG — Jivi 2026-07-23
- CHMP opinion BAYN.DE Bayer AG CHMP agenda item: Bayer AG — Xofigo 2026-07-23
- CHMP opinion BIIB Biogen Inc. CHMP agenda item: Biogen Inc. — Skyclarys 2026-07-23
- CHMP opinion BIIB Biogen Inc. CHMP agenda item: Biogen Inc. — Spinraza 2026-07-23
- CHMP opinion BIIB Biogen Inc. CHMP agenda item: Biogen Inc. — TECFIDERA 2026-07-23
- CHMP opinion GILD Gilead Sciences, Inc. CHMP agenda item: Gilead Sciences, Inc. — Biktarvy 2026-07-23
- CHMP opinion GILD Gilead Sciences, Inc. CHMP positive opinion: Gilead Sciences, Inc. — Trodelvy 2026-07-23
- CHMP opinion GRFS Grifols, S.A. CHMP agenda item: Grifols, S.A. — Flebogamma DIF 2026-07-23
- CHMP opinion INCY Incyte Corporation CHMP agenda item: Incyte Corporation — Pemazyre 2026-07-23
- CHMP opinion JAZZ Jazz Pharmaceuticals plc CHMP agenda item: Jazz Pharmaceuticals plc — Epidyolex 2026-07-23
- CHMP opinion KRYS Krystal Biotech, Inc. CHMP agenda item: Krystal Biotech, Inc. — Vyjuvek 2026-07-23
- CHMP opinion LUN.CO H. Lundbeck A/S CHMP agenda item: H. Lundbeck A/S — Vyepti 2026-07-23
- CHMP opinion MDGL Madrigal Pharmaceuticals, Inc. CHMP agenda item: Madrigal Pharmaceuticals, Inc. — Rezdiffra 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP agenda item: Novartis AG — Cosentyx 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP agenda item: Novartis AG — Galvus Eucreas Jalra Zomarist Icandra Xiliarx 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP agenda item: Novartis AG — Kesimpta 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP agenda item: Novartis AG — Mayzent 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP positive opinion: Novartis AG — Piqray 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP agenda item: Novartis AG — Scemblix 2026-07-23
- CHMP opinion NOVN.SW Novartis AG CHMP agenda item: Novartis AG — Zolgensma 2026-07-23
- CHMP opinion NOVO-B.CO Novo Nordisk A/S CHMP agenda item: Novo Nordisk A/S — Wegovy 2026-07-23
- CHMP opinion PA8.DE Paion AG CHMP agenda item: Paion AG — Xerava 2026-07-23
- CHMP opinion ROG.SW Roche Holding AG CHMP agenda item: Roche Holding AG — Enspryng 2026-07-23
- CHMP opinion ROG.SW Roche Holding AG CHMP agenda item: Roche Holding AG — Lunsumio 2026-07-23
- CHMP opinion ROG.SW Roche Holding AG CHMP agenda item: Roche Holding AG — Ocrevus 2026-07-23
- CHMP opinion ROG.SW Roche Holding AG CHMP agenda item: Roche Holding AG — Polivy 2026-07-23
- CHMP opinion ROG.SW Roche Holding AG CHMP positive opinion: Roche Holding AG — Susvimo 2026-07-23
- CHMP opinion ROG.SW Roche Holding AG CHMP agenda item: Roche Holding AG — Vabysmo 2026-07-23
- CHMP opinion SANN.SW Santhera Pharmaceuticals Holding AG CHMP agenda item: Santhera Pharmaceuticals Holding AG — AGAMREE 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Arava 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Dupixent 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Kevzara 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Lantus 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Suliqua 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Teizeild 2026-07-23
- CHMP opinion SNY Sanofi CHMP agenda item: Sanofi — Toujeo 2026-07-23
- CHMP opinion VRTX Vertex Pharmaceuticals Incorporated CHMP agenda item: Vertex Pharmaceuticals Incorporated — Alyftrek 2026-07-23
- CHMP opinion VRTX Vertex Pharmaceuticals Incorporated CHMP agenda item: Vertex Pharmaceuticals Incorporated — Kaftrio 2026-07-23
- CHMP opinion VTRS Viatris Inc. CHMP positive opinion: Viatris Inc. — Ruxolitinib Viatris 2026-07-23
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.